TislelizumabMembranous nephropathy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1899卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12327-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：355 / 355

相关论文

共 50 条

[1] BevacizumabMembranous nephropathy: case report
Reactions Weekly, 2017, 1657 (1) : 80 - 80
[2] AdalimumabIgA nephropathy: case report
Reactions Weekly, 2022, 1887 (1) : 23 - 23
[3] TozinameranIgA nephropathy: case report
Reactions Weekly, 2022, 1923 (1) : 470 - 470
[4] SulfadiazineCrystal nephropathy: case report
Reactions Weekly, 2023, 1967 (1) : 328 - 328
[5] PenicillamineMembranous nephropathy: case report
Reactions Weekly, 2021, 1865 (1) : 358 - 358
[6] NivolumabIgA Nephropathy: case report
Reactions Weekly, 2018, 1684 (1) : 195 - 195
[7] LevofloxacinOxalate nephropathy: case report
Reactions Weekly, 2019, 1737 (1) : 181 - 181
[8] LevamisoleMembranous nephropathy: case report
Reactions Weekly, 2018, 1699 (1) : 181 - 181
[9] IpilimumabIgA nephropathy: case report
Reactions Weekly, 2022, 1893 (1) : 191 - 191
[10] EtanerceptMembranous nephropathy: case report
Reactions Weekly, 2021, 1861 (1) : 127 - 127

← 1 2 3 4 5 →